Close
Nordic 9Nordic 9

Enara Bio (private company)

United Kingdom enarabio.com
See something wrong or missing? Let us know
Offices:London
Industry:BiotechHealth servicesPharma
Business model:B2B

Enara Bio (formerly Ervaxx) is a British cancer immunotherapy startup  targeting the T-cell/cancer cell interface (the “immune synapse”) to develop new targeted cancer immunotherapies designed to treat a broad patient population.

Investors: we tracked 5 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 50M

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Enara Bio

Name Criteria
France AbolerIS Pharma
63%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 4
  • Total raised in a similar range: 10M+ USD
Denmark Acesion Pharma
63%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Sweden Cinclus Pharma
63%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
Denmark NMD Pharma
63%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
United Kingdom ReViral
63%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 4
  • Total raised in a similar range: 10M+ USD
Spain Sanifit Therapeutics
63%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 4
  • Total raised in a similar range: 10M+ USD
Denmark STipe Therapeutics
63%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Denmark Synklino
63%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
United Kingdom Theolytics
63%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
United Kingdom Exiscientia
63%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 4
  • Total raised in a similar range: 10M+ USD
Top